• Opinion
• [Reporter’s View] Reliability Verification Review Committee
• by Lee, Hye-Kyung Jun 20, 2024 05:48am

• Opinion
• [Reporter’s View] Finances limit reimbursement of drugs
• by Eo, Yun-Ho Jun 7, 2024 05:51am

• Opinion
• [Reporter's View] Expectations for new Alzheimer's drugs
• by Son, Hyung-Min Jun 5, 2024 05:47am

• Opinion
• [Reporter’s View] An open talk on improving the GMP system
• by Lee, Hye-Kyung Jun 5, 2024 05:47am

• Opinion
• [Reporter’s View] We don’t know the fate of rivoceranib
• by Kim, Jin-Gu May 30, 2024 05:50am

• Opinion
• [Reporter’s View] Lung cancer but also a 'rare disease'
• by Eo, Yun-Ho May 27, 2024 05:48am

• Opinion
• [Reporter’s View] Drug Review Coordination Council
• by Kim, Jin-Gu May 16, 2024 05:48am

• Opinion
• [Reporter’s View] MFDS’ Regulatory Innovation 3.0
• by Lee, Hye-Kyung May 14, 2024 05:48am

• Opinion
• [Reporter’s View] The dark side of the coveted MNC jobs
• by Eo, Yun-Ho May 10, 2024 05:47am

• Opinion
• [Reporter’s View] Patients are left to suffer amid dispute
• by Lee, Jeong-Hwan Apr 29, 2024 05:50am